KATHRYN TADLOCK: Open Payments
NPI 1851622740 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 34 payments from 12 companies in 2025. Trend: 2023 $1,131 · 2024 $1,210 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 7 | $190 |
| Lilly USA, LLC | 4 | $113 |
| LEO Pharma Inc. | 4 | $91 |
| Galderma Laboratories, L.P. | 3 | $75 |
| Janssen Biotech, Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Amgen Inc. | 3 | $60 |
| ABBVIE INC. | 1 | $56 |
| Incyte Corporation | 2 | $51 |
| PFIZER INC. | 2 | $50 |
Products named: VTAMA, TALTZ, TREMFYA, ANZUPGO, COSENTYX, OTEZLA, NEMLUVIO, BOTOX.
Industry payments across CA — which companies pay providers there.
